Lot

HAL-202608-152

Purity

99.31%

As supplied

Form: Lyophilised powder
Storage: −20 °C, desiccated
Stability: 24 months
CAS: 218949-48-5
Formula: C221H366N72O67S
Molecular weight: 5135.87 g/mol
Solubility: Bacteriostatic water or 0.9% NaCl, ≥2 mg/mL

Tesamorelin

Trans-3-hexenoyl GHRH(1-44) analogue

Halden Laboratories Compare brands

£88

Vial massTESAMORELIN-2-HAL

70 vials in stock · dispatched within 24 h

A 44-residue GHRH analogue carrying an N-terminal trans-3-hexenoyl moiety. Long-chain synthesis; each lot carries extended purity documentation given the sequence length.

Long-chain SPPSAnalogue stability

Supplied for laboratory research use only. Not for human or veterinary use, consumption, or clinical application.

Analysis

Certificate of analysis

RP-HPLC chromatogramJanoshik Analytical

Retention time (min)λ 214 nm

Purity99.31%

Specification ≥ 98.0%

Lot: HAL-202608-152
Released: 2026-08-22
Mass expected: 5135.87 Da
Mass found: 5136.06 Da
Water (KF): 3.13%
Endotoxin: 0.118 EU/mg
Appearance: White lyophilisate

Signed COA · Tesamorelin HAL-202608-152PDF ↓

Primary structure

44 residues

Hover a residue for detail

Formula: C221H366N72O67S
Molecular weight: 5135.87 g/mol

Interactive

Reconstitution

Vial mass

Bacteriostatic watermL

Target quantity per drawmcg

Syringe

Draw to: 25.0 units
Volume: 0.250 mL
Concentration: 1.00 mg/mL
Draws per vial: 8

Arithmetic for Tesamorelin at the values you entered. Not a protocol and not a dose recommendation. Research use only.

Handling

On arrival: Transfer to −20 °C within two hours. Vials ship on phase-change packs rated for 72 hours.
Reconstitution: Bacteriostatic water or 0.9% NaCl, ≥2 mg/mL
After reconstitution: 2–8 °C, use within 28 days. Aliquot to avoid freeze-thaw cycling.
Shelf life: 24 months lyophilised, desiccated and protected from light.